Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis
- PMID: 9234807
- PMCID: PMC175484
- DOI: 10.1128/iai.65.8.3422-3429.1997
Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis
Abstract
We produced disseminated trichosporonosis in a neutropenic murine model with Trichosporon asahii, which was identified by DNA relatedness analysis. We then assessed the efficacy of granulocyte colony-stimulating factor (G-CSF) (30 to 100 microg/kg of body weight per day) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (0.8 to 2 microg/kg x day). The administration of G-CSF either before or after infection improved the survival rate from less than 25% up to 100% (P < 0.05). The effects of G-CSF on organ clearance and histological examinations were most remarkable in the lungs. The levels of tumor necrosis factor alpha (TNF-alpha) in bronchoalveolar lavage fluid (BALF) of neutropenic and G-CSF-pretreated mice were 60 +/- 6 ng/ml and 18 +/- 6 pg/ml, respectively, at 24 h after infection. Immunohistologically, alveolar macrophages proved to be the main source of TNF-alpha in BALF. GM-CSF increased neutrophil counts less significantly than did G-CSF and increased the lethality (P < 0.05) with a high level of TNF-alpha in BALF. Expecting to inhibit TNF-alpha, we administered anti-TNF-alpha intraperitoneally at the dose completely inhibiting TNF-alpha in plasma (2 x 10(4) U), but the TNF-alpha level in BALF and the lethality increased. Though the number of neutrophils at the early stage of infection appeared to be the most critical, the results suggest that other host defense mechanisms, such as TNF-alpha overproduction in the lungs, have an important role in the prognosis of trichosporonosis.
Similar articles
-
Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii.Clin Exp Immunol. 2000 Feb;119(2):293-8. doi: 10.1046/j.1365-2249.2000.01134.x. Clin Exp Immunol. 2000. PMID: 10632665 Free PMC article.
-
Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.Am J Pathol. 2001 Oct;159(4):1423-33. doi: 10.1016/S0002-9440(10)62529-1. Am J Pathol. 2001. PMID: 11583970 Free PMC article.
-
Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.Biol Neonate. 2001 Aug;80(2):133-41. doi: 10.1159/000047132. Biol Neonate. 2001. PMID: 11509813
-
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857. J Infect Dis. 1999. PMID: 10081506 Review.
-
The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.Paediatr Drugs. 2003;5(10):673-84. doi: 10.2165/00148581-200305100-00003. Paediatr Drugs. 2003. PMID: 14510625 Review.
Cited by
-
The Effects of Granulocyte Colony-Stimulating Factor (G-CSF) in Pre-Clinical Models of Infection and Acute Inflammation.Sepsis (Boston). 1998;2(3):213-220. doi: 10.1023/A:1009829712638. Sepsis (Boston). 1998. PMID: 32288620 Free PMC article. No abstract available.
-
Recombinant murine granulocyte-macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice.Antimicrob Agents Chemother. 2000 Dec;44(12):3328-36. doi: 10.1128/AAC.44.12.3328-3336.2000. Antimicrob Agents Chemother. 2000. PMID: 11083636 Free PMC article.
-
Experimental pathogenicity of a clinical isolate of Trichosporon dermatis in a murine model.Mycopathologia. 2011 Nov;172(5):381-7. doi: 10.1007/s11046-011-9442-6. Epub 2011 Jul 13. Mycopathologia. 2011. PMID: 21750940
-
Host immune response against Scedosporium species.Med Mycol. 2009 Jun;47(4):433-40. doi: 10.1080/13693780902738006. Epub 2009 Jan 31. Med Mycol. 2009. PMID: 19184770 Free PMC article. Review.
-
Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii.Clin Exp Immunol. 2000 Feb;119(2):293-8. doi: 10.1046/j.1365-2249.2000.01134.x. Clin Exp Immunol. 2000. PMID: 10632665 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical